Table 3 Cumulative dosage of each anti-psoriatic treatment between the initiation date of each treatment and malignancy without NMSC.

From: Risk of malignancy in patients with psoriasis according to treatment modalities in Korea: a nationwide cohort study

Treatment

Dosage

Event (n)

Mean

SD

Phototherapy

261

44.1

46.7

Non-biologic systemics

Acitretin (mg)

333

4970.7

5649.2

Cyclosporin (mg)

188

35054.7

50603.5

Methotrexate (mg)

134

471.5

709.1

Biologics

Adalimumab (mg)

7

1154.3

861.8

Etanercept (mg)

2

5765.0

4688.1

Infliximab (mg)

2

5000.0

5798.3

Ustekinumab (mg)

14

507.9

329.0

Guselkumab (mg)

0

–

–

Secukinumab (mg)

0

–

–

Ixekizumab (mg)

0

–

–

  1. NMSC, nonmelanoma skin cancer; SD, standard deviation.
Back to article page